# Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)

> **NCT00957346** · PHASE3 · TERMINATED · sponsor: **Gynuity Health Projects** · enrollment: 20 (estimated)

## Conditions studied

- Abortion, Induced

## Interventions

- **DRUG:** Mifepristone+misoprostol
- **DRUG:** Placebo+Misoprostol

## Key facts

- **NCT ID:** NCT00957346
- **Lead sponsor:** Gynuity Health Projects
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00957346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00957346, "Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00957346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*